Peptide Injections AI
2026 FDA Reclassification

Peptides for Fat Loss

Targeted peptide therapy can mobilize stubborn fat while preserving lean muscle mass, a different approach than simple calorie restriction.

ByChris Riley(CFA)&Alex Evans, PharmD, MBA(PharmD, MBA)|Updated

Fat Loss Peptide Therapy Overview

While weight loss peptides like GLP-1s reduce appetite, fat loss peptides work differently by targeting fat cell metabolism directly. AOD-9604 is a fragment of human growth hormone that stimulates lipolysis (fat breakdown) without the blood sugar and growth effects of full HGH. MOTS-C targets mitochondrial function and metabolic regulation.

  • Targeted lipolysis in stubborn fat areas
  • Preservation of lean muscle mass
  • No impact on blood sugar or insulin
  • Improved metabolic rate
  • Stackable with GLP-1s for enhanced results

How Fat Loss Peptides Work

Fat loss peptides target adipose tissue metabolism directly rather than suppressing appetite. AOD-9604 is amino acids 177–191 of the human growth hormone molecule — the lipolytic (fat-burning) region. It binds to beta-3 adrenergic receptors on fat cells, activating hormone-sensitive lipase to break down stored triglycerides into free fatty acids for energy use. Crucially, it does NOT activate the IGF-1 pathway, so it avoids the blood sugar, insulin, and growth effects of full HGH. MOTS-C is a mitochondrial-derived peptide that activates AMPK (the cell's energy sensor), increasing fat oxidation and improving insulin sensitivity — essentially mimicking exercise at the metabolic level. CJC-1295 + Ipamorelin shift body composition by elevating natural GH, which partitions calories toward lean mass instead of fat storage.

Fat Loss Peptide Clinical Evidence & Data

50% increase in lipolysis

AOD-9604 Preclinical Data

AOD-9604 stimulated fat breakdown in obese mice without affecting IGF-1 or insulin levels

AMPK activation (exercise mimetic)

MOTS-C Research

MOTS-C activates the same metabolic pathway as exercise, improving fat oxidation and glucose uptake

No blood sugar impact

AOD-9604 Safety Profile

Unlike full HGH, AOD-9604 showed no effect on blood glucose or insulin resistance in human studies

Peptides Used for Fat Loss

AOD-9604CompoundedRFK 2026

HGH fragment targeting fat cells with no blood sugar or growth effects

MOTS-CResearchRFK 2026

Mitochondrial peptide for metabolic regulation and fat oxidation

CJC-1295 + IpamorelinCompoundedRFK 2026

GH stack promoting lipolysis and lean body composition

Who Is Fat Loss Peptide Therapy For?

Fat loss peptide therapy is suited for adults who are already at or near a healthy weight but struggling with stubborn subcutaneous fat that doesn't respond to diet and exercise, sometimes called "skinny fat." It's also popular among athletes optimizing body composition for performance. AOD-9604 is a good option for patients who want fat loss benefits of GH without the side effects. Not appropriate as a standalone obesity treatment — for significant weight loss (BMI ≥30), GLP-1 agonists are more effective.

Typical Fat Loss Peptide Protocol

Fat loss peptide protocols often stack multiple compounds. AOD-9604 is typically dosed at 250–300mcg subcutaneously daily, ideally in the morning on an empty stomach (fasting maximizes lipolysis). MOTS-C is dosed at 5–10mg weekly via SC injection. CJC-1295/Ipamorelin (100mcg each) is administered before bed to amplify the nocturnal GH pulse that drives fat metabolism during sleep. Many providers combine fat loss peptides with GLP-1s for a dual mechanism — reduced appetite plus enhanced fat metabolism. Protocols typically run 8–12 weeks with labs (fasting insulin, lipid panel, body composition DEXA) at baseline and 8 weeks.

Fat Loss Peptide News

News aggregated via Google News. Inclusion does not imply endorsement.

Fat Loss Guides & Resources

Fat Loss Peptide FAQs

What is the difference between fat loss and weight loss peptides?

Weight loss peptides like GLP-1s primarily reduce appetite. Fat loss peptides like AOD-9604 directly target fat cell metabolism, stimulating lipolysis without affecting appetite. Many providers combine both approaches for optimal body composition results.

Does AOD-9604 actually work for fat loss?

AOD-9604 has shown promise in animal studies and clinical observations, but rigorous human clinical trials are limited. It is one of the peptides being reclassified for legal compounding in 2026. Many practitioners report positive results when combined with diet and exercise protocols.

Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Peptide therapies discussed here may not be FDA-approved for the listed indications. All prices shown are estimates based on publicly available data and may not reflect current pricing — providers and brands set their own prices and can change them at any time. Always verify pricing directly with the provider before purchasing. Consult a licensed healthcare provider before starting any peptide protocol.

Find a Provider for Fat Loss

Take our 2-minute quiz to get matched with a board-certified provider specializing in fat loss peptide therapy.